Krystal Biotech, Inc. (KRYS)
305.19
-0.49
(-0.16%)
USD |
NASDAQ |
Nov 13, 16:00
305.19
0.00 (0.00%)
After-Hours: 19:59
Krystal Biotech Market Cap : 9.043B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 9.058B |
| November 11, 2026 | 9.150B |
| November 10, 2026 | 9.082B |
| November 09, 2026 | 8.980B |
| November 06, 2026 | 8.915B |
| November 05, 2026 | 8.897B |
| November 04, 2026 | 9.210B |
| November 03, 2026 | 9.038B |
| November 02, 2026 | 8.768B |
| October 30, 2026 | 9.846B |
| October 29, 2026 | 9.617B |
| October 28, 2026 | 9.513B |
| October 27, 2026 | 9.488B |
| October 26, 2026 | 9.283B |
| October 23, 2026 | 9.219B |
| October 22, 2026 | 9.475B |
| October 21, 2026 | 9.535B |
| October 20, 2026 | 9.631B |
| October 19, 2026 | 9.478B |
| October 16, 2026 | 9.370B |
| October 15, 2026 | 9.767B |
| October 14, 2026 | 9.787B |
| October 13, 2026 | 9.505B |
| October 12, 2026 | 9.828B |
| October 09, 2026 | 9.814B |
| Date | Value |
|---|---|
| October 08, 2026 | 9.687B |
| October 07, 2026 | 9.606B |
| October 06, 2026 | 9.672B |
| October 05, 2026 | 9.910B |
| October 02, 2026 | 9.538B |
| October 01, 2026 | 9.628B |
| September 30, 2026 | 9.842B |
| September 29, 2026 | 9.916B |
| September 28, 2026 | 9.976B |
| September 25, 2026 | 10.23B |
| September 24, 2026 | 10.21B |
| September 23, 2026 | 10.11B |
| September 22, 2026 | 10.38B |
| September 21, 2026 | 9.881B |
| September 18, 2026 | 9.964B |
| September 17, 2026 | 10.03B |
| September 16, 2026 | 9.964B |
| September 15, 2026 | 9.964B |
| September 14, 2026 | 10.06B |
| September 11, 2026 | 10.27B |
| September 10, 2026 | 10.23B |
| September 09, 2026 | 10.30B |
| September 08, 2026 | 10.40B |
| September 04, 2026 | 10.60B |
| September 03, 2026 | 10.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Alnylam Pharmaceuticals, Inc. | 22.09B |
| Ionis Pharmaceuticals, Inc. | 4.833B |
| Ultragenyx Pharmaceutical, Inc. | 1.638B |
| BridgeBio Pharma, Inc. | 15.35B |
| Cytokinetics, Inc. | 7.806B |
Market Cap Related Metrics
| PE Ratio | 41.44 |
| PS Ratio | 19.84 |
| PEG Ratio | 3.963 |
| Price to Book Value | 6.299 |
| Price to Free Cash Flow | 30.08 |
| Price | 305.19 |
| Earnings Yield | 2.41% |
| PEGY Ratio | 3.963 |
| Operating PE Ratio | 41.00 |
| Normalized PE Ratio | 41.44 |